Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with primary breast cancer
Female, ≥18 years old (at index date)
HR positive
Receive Zoladex® 10.8 mg or Zoladex® 3.6 mg treatment
Premenopausal status prior to the treatment of Zoladex®. Baseline premenopausal status will be confirmed if the patient's last E2 measurement within 180 days prior to the index date indicated premenopausal status or there was a recorded menstrual history within 180 days prior to the index date
You may not be if
Patients received concurrent treatments that may affect E2 testing results
